COMPASS Pathways plc (CMPS)
USD 4.08
(2.39%)
USD 4.08
(2.39%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 136.91 Million USD | 42.66% |
| 2022 | 95.97 Million USD | 30.45% |
| 2021 | 73.57 Million USD | 56.05% |
| 2020 | 47.14 Million USD | 155.54% |
| 2019 | 18.45 Million USD | 75.08% |
| 2018 | 10.53 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 47.89 Million USD | 10.56% |
| 2024 Q2 | 43.32 Million USD | 12.31% |
| 2024 Q1 | 38.57 Million USD | -0.43% |
| 2023 Q1 | 27.47 Million USD | -1.0% |
| 2023 FY | 137.2 Million USD | 42.95% |
| 2023 Q4 | 38.73 Million USD | 23.46% |
| 2023 Q3 | 31.37 Million USD | 4.09% |
| 2023 Q2 | 30.14 Million USD | 9.73% |
| 2022 Q2 | 23.17 Million USD | 3.03% |
| 2022 Q1 | 22.49 Million USD | -11.45% |
| 2022 FY | 95.97 Million USD | 30.45% |
| 2022 Q4 | 27.74 Million USD | 23.04% |
| 2022 Q3 | 22.55 Million USD | -2.7% |
| 2021 FY | 73.57 Million USD | 56.05% |
| 2021 Q4 | 25.4 Million USD | 32.68% |
| 2021 Q3 | 19.15 Million USD | 12.85% |
| 2021 Q2 | 16.97 Million USD | 40.89% |
| 2021 Q1 | 12.04 Million USD | 15.27% |
| 2020 Q1 | 7.63 Million USD | 20.08% |
| 2020 Q4 | 10.44 Million USD | -15.67% |
| 2020 Q3 | 12.39 Million USD | -25.71% |
| 2020 Q2 | 16.67 Million USD | 118.6% |
| 2020 FY | 47.14 Million USD | 155.54% |
| 2019 Q1 | 2.69 Million USD | 0.0% |
| 2019 FY | 18.45 Million USD | 75.08% |
| 2019 Q4 | 6.35 Million USD | 10.66% |
| 2019 Q3 | 5.74 Million USD | 59.59% |
| 2019 Q2 | 3.59 Million USD | 33.31% |
| 2018 FY | 10.53 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | 22.211% |
| Addus HomeCare Corporation | 248.92 Million USD | 44.995% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | -15.717% |
| Amedisys, Inc. | 834.47 Million USD | 83.592% |
| Astrana Health, Inc. | 112.59 Million USD | -21.601% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 76.689% |
| IMAC Holdings, Inc. | 5.02 Million USD | -2623.604% |
| biote Corp. | 98.82 Million USD | -38.546% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -288.915% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 59.455% |
| DocGo Inc. | 180.32 Million USD | 24.072% |
| The Ensign Group, Inc. | 335.39 Million USD | 59.176% |
| Healthcare Services Group, Inc. | 189.09 Million USD | 27.591% |
| InnovAge Holding Corp. | 558.25 Million USD | 75.474% |
| The Joint Corp. | 109.22 Million USD | -25.357% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 72.127% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -650.565% |
| ModivCare Inc. | 586.89 Million USD | 76.671% |
| NewGenIvf Group Limited | 1.63 Million USD | -8251.047% |
| Option Care Health, Inc. | 666.62 Million USD | 79.461% |
| P3 Health Partners Inc. | 199.56 Million USD | 31.391% |
| P3 Health Partners Inc. | 199.56 Million USD | 31.391% |
| The Pennant Group, Inc. | 88.99 Million USD | -53.85% |
| Surgery Partners, Inc. | 319.5 Million USD | 57.146% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -3084.534% |
| Talkspace, Inc. | 97.58 Million USD | -40.302% |
| Talkspace, Inc. | 97.58 Million USD | -40.302% |
| The Oncology Institute, Inc. | 136.59 Million USD | -0.24% |
| The Oncology Institute, Inc. | 136.59 Million USD | -0.24% |